Back to User profile » Dr Shiqi Peng

Papers published by Dr Shiqi Peng:


Development of 13-Cys-BBR as an Agent Having Dual Action of Anti-Thrombosis and Anti-Inflammation

Li G, Wang T, Zhang X, Zhao S, Wang Y, Wu J, Peng S, Zhao M

Drug Design, Development and Therapy 2020, 14:2187-2197

Published Date: 3 June 2020

Modifying ICCA with Trp-Phe-Phe to Enhance in vivo Activity and Form Nano-Medicine

Zhang X, Zhang Y, Wang Y, Wu J, Chen H, Zhao M, Peng S

International Journal of Nanomedicine 2020, 15:465-481

Published Date: 21 January 2020

13-[CH2CO-Cys-(Bzl)-OBzl]-Berberine: Exploring The Correlation Of Anti-Tumor Efficacy With ROS And Apoptosis Protein

Li G, Ren Y, Zhang X, Zhao S, Wang Y, Wu J, Peng S, Zhao M

OncoTargets and Therapy 2019, 12:10651-10662

Published Date: 5 December 2019

RGDV-modified gemcitabine: a nano-medicine capable of prolonging half-life, overcoming resistance and eliminating bone marrow toxicity of gemcitabine

Liu W, Mao Y, Zhang X, Wang Y, Wu J, Zhao S, Peng S, Zhao M

International Journal of Nanomedicine 2019, 14:7263-7279

Published Date: 6 September 2019

Nano-scaled MTCA-KKV: for targeting thrombus, releasing pharmacophores, inhibiting thrombosis and dissolving blood clots in vivo

Zhao S, Li Z, Huang F, Wu J, Gui L, Zhang X, Wang Y, Wang X, Peng S, Zhao M

International Journal of Nanomedicine 2019, 14:4817-4831

Published Date: 3 July 2019

BCESA: a nano-scaled intercalator capable of targeting tumor tissue and releasing anti-tumoral β-carboline-3-carboxylic acid

Wu J, Cui Y, Zhang X, Gui L, Wang Y, Peng S, Zhao M

International Journal of Nanomedicine 2019, 14:3027-3041

Published Date: 30 April 2019

Design and development of ICCA as a dual inhibitor of GPIIb/IIIa and P-selectin receptors

Chen H, Lu A, Zhang X, Gui L, Wang YN, Wu J, Feng H, Peng S, Zhao M

Drug Design, Development and Therapy 2018, 12:2097-2110

Published Date: 9 July 2018

Design and synthesis of nanoscaled IQCA-TAVV as a delivery system capable of antiplatelet activation, targeting arterial thrombus and releasing IQCA

Wu J, Zhu H, Yang G, He J, Wang Y, Zhao S, Zhang X, Gui L, Zhao M, Peng S

International Journal of Nanomedicine 2018, 13:1139-1158

Published Date: 26 February 2018

ATIQCTPC: a nanomedicine capable of targeting tumor and blocking thrombosis in vivo

Xu X, Wang Y, Wu J, Hu X, Zhu H, Zhang X, Wang YN, Gui L, Zhao M, Peng S

International Journal of Nanomedicine 2017, 12:4415-4431

Published Date: 13 June 2017

N-(3-hydroxymethyl-β-carboline-1-yl-ethyl-2-yl)-L-Phe: development toward a nanoscaled antitumor drug capable of treating complicated thrombosis and inflammation

Wu JH, Zhao M, Wang YJ, Wang YN, Zhu HM, Zhao SR, Gui L, Zhang XY, Peng SQ

Drug Design, Development and Therapy 2017, 11:225-239

Published Date: 17 January 2017

Loading cisplatin onto 6-mercaptopurine covalently modified MSNS: a nanomedicine strategy to improve the outcome of cisplatin therapy

Lv X, Zhao M, Wang Y, Hu X, Wu J, Jiang X, Li S, Cui C, Peng S

Drug Design, Development and Therapy 2016, 10:3933-3946

Published Date: 1 December 2016

Nanomedical strategy to prolong survival period, heighten cure rate, and lower systemic toxicity of S180 mice treated with MTX/MIT

Song N, Zhao M, Wang Y, Hu X, Wu J, Jiang X, Li S, Cui C, Peng S

Drug Design, Development and Therapy 2016, 10:2701-2711

Published Date: 30 August 2016

RGD(F/S/V)-Dex: towards the development of novel, effective, and safe glucocorticoids

Jiang X, Zhao M, Wang Y, Zhu H, Zhao S, Wu J, Song Y, Peng S

Drug Design, Development and Therapy 2016, 10:1059-1076

Published Date: 8 March 2016

Aqueous extract of Rabdosia rubescens leaves: forming nanoparticles, targeting P-selectin, and inhibiting thrombosis

Wang Y, Tang J, Zhu H, Jiang X, Liu J, Xu W, Ma H, Feng Q, Wu J, Zhao M, Peng S

International Journal of Nanomedicine 2015, 10:6905-6918

Published Date: 4 November 2015

Modifying tetramethyl–nitrophenyl–imidazoline with amino acids: design, synthesis, and 3D-QSAR for improving inflammatory pain therapy

Jiang X, Wang Y, Zhu H, Wang Y, Zhao M, Zhao S, Wu J, Li S, Peng S

Drug Design, Development and Therapy 2015, 9:2329-2342

Published Date: 22 April 2015

Cu2+-RGDFRGDS: exploring the mechanism and high efficacy of the nanoparticle in antithrombotic therapy

Wu J, Wang Y, Wang Y, Zhao M, Zhang X, Gui L, Zhao S, Zhu H, Zhao J, Peng S

International Journal of Nanomedicine 2015, 10:2925-2938

Published Date: 15 April 2015